Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy

NCT00410696 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Hematological Neoplasms
Tumors

Interventions

DRUG: Filgrastim
DRUG: Pegfilgrastim

Sponsor

Armando Santoro, MD